biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Sniper007on Nov 25, 2016 7:18pm

86 Views

Post# 25515933

RE:RE:RE:well well well

Regardless, the year's not over, so stop pretending it is. All you're doing polluting this board with your crapp. When the year is over, and if you're right, feel free to smear it in. Until then, shut it you moron. I bet KayakerBC regrets ever doing that "fun" guessing game. Too bad it's people like you and beenthere that have to ruin it. Sniper

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario